SEC Form 4 · accession 0001179110-15-011121
Bellerophon Therapeutics, Inc. · BLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Agrawal
Officer — Chief Operating Officer
Period of report
Jul 8, 2015
Accepted (ET)
Jul 13, 2015 · 6:50 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $8.23 | Jul 8, 2015 | A | 100,000 | A | — | Jul 7, 2025 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1This option was granted on July 8, 2015. This option vests in five equal annual installments, with the first installment vesting on the date of grant and the remaining four installments vesting annually on each of the first four anniversaries of the date of grant.